Table 4.
Variables | Model 1∗ | Model 2∗∗ | Model 3∗∗∗ | Model 4∗∗∗∗ |
---|---|---|---|---|
Current age | p < 0.001 | p < 0.001 | p < 0.001 | p < 0.001 |
HR 1.136 (1.084–1.224)† | HR 1.140 (1.081–1.227) | HR 1.140 (1.072–1.284) | HR 1.145 (1.083–1.290) | |
| ||||
Sex | p = 0.065 | p = 0.077 | p = 0.070 | p = 0.073 |
HR 0.761 (0.643–0.961) | HR 0.822 (0.668–1.060) | HR 0.820 (0.651–1.072) | HR 0.834 (0.644–1.015) | |
| ||||
Insulin treatment | p < 0.001 | p < 0.001 | p < 0.001 | p < 0.001 |
HR 1.218 (1.131–1.448) | HR 1.302 (1.188–1.506) | HR 1.311 (1.174–1.501) | HR 1.302 (1.178–1.545) | |
| ||||
Arterial hypertension | p = 0.05 | p = 0.05 | p = 0.045 | p = 0.049 |
HR 1.118 (0.985–1.788) | HR 1.121 (0.907–1.340) | HR 1.134 (1.002–1.161) | HR 1.367 (1.062–1.899) | |
| ||||
HbA1c | p < 0.001 | P < 0.001 | p < 0.001 | p < 0.001 |
HR 2.135 (1.893–2.408) | HR 2.089 (1.811–2.632) | HR 2.052 (1.780–2.273) | HR 2.037 (1.806–2.297) | |
| ||||
eGFR < 60 ml/min/1.73 m2 | p = 0.002 | p = 0.04 | p = 0.09 | |
HR 1.854 (1.251–4.431) | HR 1.223 (1.098–1.201) | HR 1.103 (0.078–1.311) | ||
| ||||
UACR ≥ 30 mg/g | p < 0.001 | P = 0.004 | ||
HR 1.485 (1.103–1.548) | HR 1.485 (1.092–1.465) | |||
| ||||
UACR ≥ 300 mg/g and eGFR< 30 ml/min/1.73 m2 | p < 0.001 | |||
HR 1.998 (1.682–2.305) |
Model 1∗, Cox's analysis in which the variables of renal function are not included; model 2∗∗, Cox's analysis in which we include only the eGFR variable for the study of renal function; model 3∗∗∗, Cox's analysis with eGFR and UACR as variables for the study of renal function; model 4∗∗∗∗, Cox's analysis in which we included in addition to the eGFR and the UACR, the presence of renal failure. †Hazard ratio (95% CI).